Notice Title

Consent to the Distribution of New Medicines

Publication Date
11 Sep 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go5061
Title
View PDF
File Type and Size
PDF (22 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

Product: Alphagan P 1.0
Active Ingredient: Brimonidine tartrate 1mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: AbbVie Limited
Manufacturer: Allergan Sales LLC, Texas, United States of America
   
Product: Noumed Cetirizine Hayfever & Allergy Relief
Active Ingredient: Cetirizine hydrochloride 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Noumed Pharmaceuticals Limited
Manufacturer: Gracure Pharmaceuticals Limited, Bhiwadi, India


Dated this 9th day of September 2025.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).